Clinical Trial Update: Efficacy of Intrathecal Oxytocin in Patients With Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating intrathecal oxytocin for neuropathic pain was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• intrathecal oxytocin (oxytocin)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Neuropathic Pain | Phase 2 | Status: TERMINATED | Results posted: 2023-10-03